[1]明 霞,刘 伟.血清叉头框D1在鼻咽癌患者中的表达及其与放疗后复发转移关系研究[J].陕西医学杂志,2024,(11):1495-1499.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.012]
　MING Xia,LIU Wei.Expression of serum FOXD1 in nasopharyngeal carcinoma patients and its relationship with recurrence and metastasis after radiotherapy[J].,2024,(11):1495-1499.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.012]
点击复制

血清叉头框D1在鼻咽癌患者中的表达及其与放疗后复发转移关系研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年11期
页码:
1495-1499
栏目:
临床研究
出版日期:
2024-11-05

文章信息/Info

Title:
Expression of serum FOXD1 in nasopharyngeal carcinoma patients and its relationship with recurrence and metastasis after radiotherapy
作者:
明 霞; 刘 伟
(武汉市第一医院耳鼻咽喉头颈外科,湖北 武汉 430022)
Author(s):
MING Xia; LIU Wei
(Department of Otolaryngology-Head and Neck Surgery,Wuhan No.1 Hospital,Wuhan 430022,China)
关键词:
鼻咽癌;  叉头框D1;  复发转移;  临床病理特征;  影响因素;  预测价值
Keywords:
Nasopharyngeal carcinoma;  Forkhead box D1;  Recurrence and metastasis;  Clinical pathological characteristics;  Influencing factor;  Predictive value
分类号:
R 739.6
DOI:
DOI:10.3969/j.issn.1000-7377.2024.11.012
文献标志码:
A
摘要:
目的:探讨血清叉头框D1(FOXD1)在鼻咽癌(NPC)患者中的表达及其与放疗后复发转移的关系。方法:选取本院NPC患者235例为NPC组,另选取同期本院体检健康志愿者246例为对照组。比较两组一般资料及血清FOXD1水平。分析血清FOXD1表达与NPC患者临床病理特征的关系。对化疗后NPC患者随访3年,记录复发转移情况。采用Cox回归分析NPC患者放疗后复发转移的影响因素。采用Spearman法分析血清FOXD1水平与肿瘤分化程度及EB病毒感染的相关性。绘制受试者工作特征(ROC)曲线分析血清FOXD1对NPC患者放疗后复发转移的预测价值。结果:NPC组FOXD1水平高于对照组(P<0.05)。NPC患者血清FOXD1表达与肿瘤分化程度、TNM分期、颈部淋巴结转移、肿瘤浸润深度、颅底侵犯、EB病毒感染有关(均P<0.05)。肿瘤低分化、EB病毒感染阳性及FOXD1高表达是NPC患者放疗后复发转移的独立危险因素(均P<0.05)。血清FOXD1水平与肿瘤分化程度呈负相关,与EB病毒感染呈正相关(均P<0.05)。FOXD1对NPC患者放疗后复发转移具有一定的预测价值(P<0.05)。结论:FOXD1在NPC患者血清中表达水平升高,与临床病理特征有关,是患者放疗后复发转移的危险因素,对放疗后复发转移具有一定的预测价值。
Abstract:
Objective:To explore the expression of serum forkhead box D1(FOXD1)in nasopharyngeal carcinoma(NPC)patients and its relationship with recurrence and metastasis after radiotherapy.Methods:A total of 235 NPC patients were selected as the NPC group,and another 246 healthy volunteers from the same period were selected as the control group.General data and serum FOXD1 levels of the two groups were compared.The relationship between serum FOXD1 expression and the clinical pathological characteristics of NPC patients was analyzed.The NPC patients were followed up for 3 years after chemotherapy,and the recurrence and metastasis were recorded.Cox regression analysis was used to analyze the influencing factors of recurrence and metastasis after radiotherapy in NPC patients.The Spearman method was used to analyze the correlation between serum FOXD1 levels and tumor differentiation and EB virus infection.The ROC curve was plotted to analyze the predictive value of serum FOXD1 for recurrence and metastasis after radiotherapy in NPC patients.Results:The FOXD1 level in the NPC group was higher than that in the control group(P<0.05).The expression of serum FOXD1 in NPC patients was correlated with tumor differentiation,TNM staging,cervical lymph node metastasis,tumor infiltration depth,skull base invasion,and EB virus infection(all P<0.05).Poor tumor differentiation,positive EB virus infection,and high expression of FOXD1 were independent risk factors for recurrence and metastasis after radiotherapy in NPC patients(all P<0.05).Serum FOXD1 levels were negatively correlated with tumor differentiation and positively correlated with EB virus infection(all P<0.05).FOXD1 had a certain predictive value for recurrence and metastasis after radiotherapy in NPC patients(P<0.05).Conclusion:The expression level of FOXD1 in the serum of NPC patients is increased and is related to clinical pathological characteristics.It is a risk factor for recurrence and metastasis after radiotherapy and has a certain predictive value for post-radiotherapy recurrence and metastasis.

参考文献/References:

[1] LI W,XU R,ZHU B,et al.Circular RNAs:Functions and mechanisms in nasopharyngeal carcinoma[J].Head Neck,2022,44(2):494-504.
[2] 吴霞,刘祥燕,雍小梅,等.放化疗前血红蛋白/血小板比值、C-反应蛋白/白蛋白比值与局部晚期鼻咽癌患者同步放化疗发生放射性骨坏死关系研究[J].陕西医学杂志,2024,53(5):632-636.
[3] JUAREZ-VIGNON W J J,AFKHAMI M,ONYSHCHENKO M,et al.Recurrent/metastatic nasopharyngeal carcinoma treatment from present to future:Where are we and where are we heading?[J].Curr Treat Options Oncol,2023,24(9):1138-1166.
[4] TABNAK P,HASANZADE-BASHKANDI A,EBRAHIMNEZHAD M,et al.Forkhead box transcription factors(FOXOs and FOXM1)in glioma:From molecular mechanisms to therapeutics[J].Cancer Cell Int,2023,23(1):238.
[5] CHENG L,YAN H,LIU Y,et al.Dissecting multifunctional roles of forkhead box transcription factor D1 in cancers[J].Biochim Biophys Acta Rev Cancer,2023,1878(6):188986.
[6] WANG F,YANG J.Correlations between forkhead box D1 expression and clinicopathological characteristics of patients with bladder cancer and influence on biological behaviors of bladder cancer cells[J].Arch Esp Urol,2022,75(3):274-281.
[7] CHEN S,YANG M,WANG C,et al.Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma[J].Cancer Lett,2021,10(3):43-53.
[8] 中国抗癌协会鼻咽癌专业委员会,李金高,陈晓钟,等.鼻咽癌复发、转移诊断专家共识[J].中华放射肿瘤学杂志,2018,27(1):7-15.
[9] MESÍA R,PASTOR M,GRAU J J,et al.SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013[J].Clin Transl Oncol,2013,15(12):1025-1029.
[10] LECHNER M,SCHARTINGER V H,STEELE C D,et al.Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection:Impact on prognosis,imaging and therapy[J].Nat Commun,2021,12(1):117.
[11] 秦晓辉,刘智强,刘俊阳,等.青天葵总黄酮对人鼻咽癌CNE-2荷瘤裸鼠皮下肿瘤的抑制作用[J].陕西中医,2024,45(5):593-599.
[12] LI J Y,ZHAO Y,GONG S,et al.TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models[J].Nat Commun,2023,14(1):865-874.
[13] JUAREZ-VIGNON W J J,AFKHAMI M,SAMPATH S,et al.Early stage and locally advanced nasopharyngeal carcinoma treatment from present to future:Where are we and where are we going?[J].Curr Treat Options Oncol,2023,24(7):845-866.
[14] TANG Y,HE X.Long non-coding RNAs in nasopharyngeal carcinoma:Biological functions and clinical applications[J].Mol Cell Biochem,2021,476(9):3537-3550.
[15] 马国辉,董艳玲,吴楠,等.养阴解毒汤对气阴两虚型晚期鼻咽癌放化疗患者免疫功能和癌因性疲乏的影响[J].陕西中医,2022,43(10):1407-1410.
[16] LAISSUE P.The forkhead-box family of transcription factors:Key molecular players in colorectal cancer pathogenesis[J].Mol Cancer,2019,18(1):25-38.
[17] 陈娜,赵佳.微小RNA-325-3p和叉头框蛋白M1在胃腺癌中的表达及靶向关系研究[J].陕西医学杂志,2023,52(3):349-353.
[18] FENG W Q,ZHANG Y C,GAO H,et al.FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β-catenin nuclear localization[J].Oncol Rep,2023,50(1):134.
[19] WANG Z,CHENG Y,ZHU Y,et al.Long non-coding RNA FOXD1-AS1 promotes the progression and glycolysis of nasopharyngeal carcinoma by sustaining FOXD1 expression[J].Am J Cancer Res,2020,10(11):3686-3704.
[20] REN D,LU J,HAN X,et al.LINC00641 contributes to nasopharyngeal carcinoma cell malignancy through FOXD1 upregulation at the post-transcriptional level[J].Biochem Cell Biol,2021,99(6):750-758.
[21] WEI J,YE J,LUO Y,et al.EB virus promotes metastatic potential by boosting STIM1-dependent Ca2+ signaling in nasopharyngeal carcinoma cells[J].Cancer Lett,2020,478:122-132.
[22] LIU X,MIN S,ZHANG Q,et al.Prognostic and clinicopathological significance of FOXD1 in various cancers:A meta and bioinformation analysis[J].Future Sci OA,2024,10(1):fso901.
[23] ZHANG B,MIAO T,SHEN X,et al.EB virus-induced ATR activation accelerates nasopharyngeal carcinoma growth via M2-type macrophages polarization[J].Cell Death Dis,2020,11(9):742-748.
[24] ZHANG B,CUI B,DU J,et al.ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human nasopharyngeal carcinoma[J].Cancer Manag Res,2019,9(11):573-585.
[25] 吴峥,郭盛虎,李文,等.FOXD1、FOXD3蛋白在食管鳞状细胞癌中的表达及与临床特征和预后的相关性[J].河北医药,2023,45(16):2452-2456.

相似文献/References:

[1]张 璇,朱海龙,哈敏文△.TGFβSMAD通路基因多态性与鼻咽癌预后相关性研究[J].陕西医学杂志,2019,(11):1430.
[2]苏建淳,张国义,卢秋霞,等.miR-124在鼻咽癌组织中的表达及其与预后关系研究*[J].陕西医学杂志,2020,49(2):144.
　SU Jianchun,ZHANG Guoyi,LU Qiuxia,et al.Expression of miR-124 in nasopharyngeal carcinoma and its relationship with prognosis[J].,2020,49(11):144.
[3]钟 亮,廖荣伟,刘清壮,等.调强适形放疗联合新辅助化疗治疗上下行型鼻咽癌疗效研究*[J].陕西医学杂志,2020,49(8):964.[doi:DOI:10.3969/j.issn.1000-7377.2020.08.013]
　ZHONG Liang,LIAO Rongwei,LIU Qingzhuang,et al.Effect of intensity-modulated radiotherapy combined with neoadjuvant chemotherapy in treatment of ascending and descending types of nasopharyngeal carcinoma[J].,2020,49(11):964.[doi:DOI:10.3969/j.issn.1000-7377.2020.08.013]
[4]易亭伍,梁 睿,宿向东.长链非编码RNA SNHG15通过miR-141-3p /KLF9机制调控鼻咽癌细胞增殖的实验研究[J].陕西医学杂志,2021,50(1):10.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.003]
　YI Tingwu,LIANG Rui,SU Xiangdong.Study on long chain non-coding RNA SNHG15 regulating the proliferation of nasopharyngeal carcinoma cells through miR-141-3p/KLF9[J].,2021,50(11):10.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.003]

备注/Memo

备注/Memo:
基金项目:湖北省卫生健康委员会科研项目(WJ2021H151)
更新日期/Last Update: 2024-11-04